Literature DB >> 28340507

Understanding the contribution of disulfide bridges to the folding and misfolding of an anti-Aβ scFv.

Laia Montoliu-Gaya1, Jose C Martínez2, Sandra Villegas1.   

Abstract

ScFv-h3D6 is a single chain variable fragment that precludes Aβ peptide-induced cytotoxicity by withdrawing Aβ oligomers from the amyloid pathway to the worm-like pathway. Production of scFv molecules is not a straightforward procedure because of the occurrence of disulfide scrambled conformations generated in the refolding process. Here, we separately removed the disulfide bond of each domain and solved the scrambling problem; and then, we intended to compensate the loss of thermodynamic stability by adding three C-terminal elongation mutations, previously described to stabilize the native fold of scFv-h3D6. Such stabilization occurred through stabilization of the intermediate state in the folding pathway and destabilization of a different, β-rich, intermediate state driving to worm-like fibrils. Elimination of the disulfide bridge of the less stable domain, VL , deeply compromised the yield and increased the aggregation tendency, but elimination of the disulfide bridge of the more stable domain, VH , solved the scrambling problem and doubled the production yield. Notably, it also changed the aggregation pathway from the protective worm-like morphology to an amyloid one. This was so because a partially unfolded intermediate driving to amyloid aggregation was present, instead of the β-rich intermediate driving to worm-like fibrils. When combining with the elongation mutants, stabilization of the partially unfolded intermediate driving to amyloid fibrils was the only effect observed. Therefore, the same mutations drove to completely different scenarios depending on the presence of disulfide bridges and this illustrates the relevance of such linkages in the stability of different intermediate states for folding and misfolding.
© 2017 The Protein Society.

Entities:  

Keywords:  aggregation; amyloid fibrils; disulfide bonds; folding; intermediate state; misfolding; worm-like fibrils

Mesh:

Substances:

Year:  2017        PMID: 28340507      PMCID: PMC5441429          DOI: 10.1002/pro.3164

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  28 in total

Review 1.  Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein.

Authors:  D J Selkoe
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

2.  FTIR reveals structural differences between native beta-sheet proteins and amyloid fibrils.

Authors:  Giorgia Zandomeneghi; Mark R H Krebs; Margaret G McCammon; Marcus Fändrich
Journal:  Protein Sci       Date:  2004-11-10       Impact factor: 6.725

3.  Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment.

Authors:  R D Terry; E Masliah; D P Salmon; N Butters; R DeTeresa; R Hill; L A Hansen; R Katzman
Journal:  Ann Neurol       Date:  1991-10       Impact factor: 10.422

Review 4.  Disulfide bond formation and its impact on the biological activity and stability of recombinant therapeutic proteins produced by Escherichia coli expression system.

Authors:  Lin Zhang; C Perry Chou; Murray Moo-Young
Journal:  Biotechnol Adv       Date:  2011-07-29       Impact factor: 14.227

Review 5.  Anti-β-amyloid immunotherapy for Alzheimer's disease: focus on bapineuzumab.

Authors:  Francesco Panza; Vincenza Frisardi; Bruno P Imbimbo; Davide Seripa; Francesco Paris; Andrea Santamato; Grazia D'Onofrio; Giancarlo Logroscino; Alberto Pilotto; Vincenzo Solfrizzi
Journal:  Curr Alzheimer Res       Date:  2011-12       Impact factor: 3.498

6.  The protective effects and underlying mechanism of an anti-oligomeric Aβ42 single-chain variable fragment antibody.

Authors:  Yuan Zhang; Xu Chen; Jinyu Liu; Yingjiu Zhang
Journal:  Neuropharmacology       Date:  2015-08-06       Impact factor: 5.250

Review 7.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

8.  Molecular structure of β-amyloid fibrils in Alzheimer's disease brain tissue.

Authors:  Jun-Xia Lu; Wei Qiang; Wai-Ming Yau; Charles D Schwieters; Stephen C Meredith; Robert Tycko
Journal:  Cell       Date:  2013-09-12       Impact factor: 41.582

9.  An intrinsically stable antibody scFv fragment can tolerate the loss of both disulfide bonds and fold correctly.

Authors:  A Wörn; A Plückthun
Journal:  FEBS Lett       Date:  1998-05-15       Impact factor: 4.124

Review 10.  Single-chain fragment variable passive immunotherapies for neurodegenerative diseases.

Authors:  Liang Huang; Xiaomin Su; Howard J Federoff
Journal:  Int J Mol Sci       Date:  2013-09-17       Impact factor: 5.923

View more
  6 in total

Review 1.  Application of Antibody Fragments Against Aβ With Emphasis on Combined Application With Nanoparticles in Alzheimer's Disease.

Authors:  Zhi-Ting Sun; Chi Ma; Guang-Jian Li; Xiang-Yu Zheng; Yi-Tong Hao; Yu Yang; Xu Wang
Journal:  Front Pharmacol       Date:  2021-04-22       Impact factor: 5.810

2.  Production of Therapeutic Single-Chain Variable Fragments (ScFv) in Pichia pastoris.

Authors:  Laia Montoliu-Gaya; Sandra Villegas
Journal:  Methods Mol Biol       Date:  2022

3.  Production of an anti-Aβ antibody fragment in Pichia pastoris and in vitro and in vivo validation of its therapeutic effect.

Authors:  Laia Montoliu-Gaya; Gisela Esquerda-Canals; Silvia Bronsoms; Sandra Villegas
Journal:  PLoS One       Date:  2017-08-03       Impact factor: 3.240

4.  Designing and generating a single-chain fragment variable (scFv) antibody against IL2Rα (CD25): An in silico and in vitro study.

Authors:  Parnian Navabi; Mohamad Reza Ganjalikhany; Sepideh Jafari; Moein Dehbashi; Mazdak Ganjalikhani-Hakemi
Journal:  Iran J Basic Med Sci       Date:  2021-03       Impact factor: 2.699

5.  A 33-residue peptide tag increases solubility and stability of Escherichia coli produced single-chain antibody fragments.

Authors:  Yang Wang; Wenjie Yuan; Siqi Guo; Qiqi Li; Xiaomei Chen; Cheng Li; Qianying Liu; Lei Sun; Zhenguo Chen; Zhenghong Yuan; Cheng Luo; Shijie Chen; Shuping Tong; Michael Nassal; Yu-Mei Wen; Yong-Xiang Wang
Journal:  Nat Commun       Date:  2022-08-08       Impact factor: 17.694

6.  Effects of an Aβ-antibody fragment on Aβ aggregation and astrocytic uptake are modulated by apolipoprotein E and J mimetic peptides.

Authors:  Laia Montoliu-Gaya; Sandra D Mulder; Robert Veerhuis; Sandra Villegas
Journal:  PLoS One       Date:  2017-11-20       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.